Varicose Veins Treatment Devices Market Size, Share and Trends Analysis Report by End Use, 2030

Varicose Veins Treatment Devices Industry Overview

The global varicose veins treatment devices market size was valued at USD 1.3 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.32% from 2023 to 2030. Increasing demand for minimally invasive procedures to treat varicose veins, along with growing investments by the market players to develop innovative and effective products, is likely to boost the market growth. According to a study published by the Institute of Quality and Efficiency in Healthcare, Germany, it is expected that approximately 20% of all adults will develop varicose veins at some point during their life span. The elderly population is more prone to spider veins although they can also affect the young population.

Moreover, the increasing geriatric population is expected to foster the growth of the market. According to World Population Prospects 2019, the number of people aged 65 years and more accounted for 703 million and is expected to double, which is 1.5 billion by 2050 globally. Varicose veins are more common among older adults and women. For instance, according to an article published in the Journal of American Heart Association, approximately 23% of U.S. adults are estimated to have varicose veins. This is anticipated to favor market growth.

Gather more insights about the market drivers, restraints, and growth of the Global Varicose Veins Treatment Devices market

Varicose veins can be aesthetically displeasing. They become problematic only in case they cause pain, aching, swelling, and considerable discomfort. In severe cases, they may rupture and can lead to ulcers. Available options for the treatment of this condition have evolved over the last few years. The majority of private healthcare providers are offering improved minimally invasive techniques.

The elderly population is more prone to the development of varicose veins. The effect of aging on the structure and functions of the veins is found to be considerable. Over the age of 50, one out of every two people is affected by varicose veins. Overweight people and pregnant women are also susceptible to developing this condition. Some of the treatments available in the market include sclerotherapy, laser therapy, and radiofrequency ablation. Sclerotherapy is preferred as a first-line of treatment for varicose, spider, and reticular veins.

Varicose veins surgical procedures are likely to undergo significant changes. Surgery has been largely replaced by noninvasive options. Due to the risk of infections associated with invasive surgeries, preference for noninvasive surgeries has increased in recent years. This factor is projected to drive the market during the forecast period. In addition to the risk of infection, noninvasive methods also involve minimum hospital stays, thus saving time and cost. More surgeons are adopting sclerotherapy, endovenous laser treatment, and radiofrequency ablation over conventional surgical practices.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Dermatology Devices Market - The global dermatology devices market size was valued at over USD 12.5 billion in 2021 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.9% over the forecast period.

Stereotactic Surgery Devices Market - The global stereotactic surgery devices market size was valued at USD 25.3 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.9% from 2023 to 2030.

Varicose Veins Treatment Devices Market Segmentation

Grand View Research has segmented the global varicose veins treatment devices market based on type, end use and region:

Varicose Veins Treatment Devices Type Outlook (Revenue, USD Million, 2017 - 2030)

• Endovenous Ablation
• Sclerotherapy
• Surgical Ligation & Stripping

End Use Outlook (Revenue, USD Million; 2017 - 2030)

• Vein Clinics
• Hospitals
• Ambulatory Care Unit

Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

December 2021: Becton, Dickinson, and Company (BD) acquired Venclose Inc. for the expansion of its business in the treatment of Chronic Venous Insufficiency.

March 2021: Medtronic launched an Investigation Device Exemption (IDE) study to determine the effectiveness and safety of the Abre venous self-expanding stent system to be used in the treatment of deep venous diseases. Around 200 subjects are likely to be enrolled in this study across 35 locations throughout the U.S. and Europe.

Key Companies profiled:

Some prominent players in the global varicose veins treatment devices market include:

• AngioDynamics
• Medtronic
• Teleflex Incorporated
• Sciton, Inc.
• Dornier Medtech
• Merit Medical Systems
• Alma Lasers
• Biolitec AG
• Boston Scientific Corporation

Order a free sample PDF of the Varicose Veins Treatment Devices Market Intelligence Study, published by Grand View Research.

Life Science Analytics Market is driven by Emergence of Advanced Analytics Method in Life Science Companies

Life Science Analytics Industry Overview

The global life science analytics market size was valued at USD 9.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.6% from 2023 to 2030. The life science industry is rapidly adopting analytics and relies on descriptive and reporting analysis in building databases and uses prescriptive and predictive analysis in estimating future trends and results, which is anticipated to propel the market growth. Another key driving force significantly impacting the life sciences industry is the rising influence of social media and the internet, which directly impacts patient engagement and drives the adoption of analytical solutions. Healthcare facilities and life science organizations are readily adopting analytical solutions to enhance clinical, financial, and operational outcomes and minimize healthcare expenditure, which will drive the market.

Life science organizations are rapidly implementing advanced analytics in their various functionalities such as supply chain, R&D activities, clinical trial designing, regulatory compliance, sales and marketing, and pharmacovigilance. Life science organizations and other healthcare industry stakeholders are rapidly adopting advanced data mining techniques and big data analytics to accurately analyze the population at high risk and strategize accordingly to drive the market. Healthcare financing organizations and government bodies are implementing predictive analytics in claims management and prevention of frauds, which is further boosting market growth.

Gather more insights about the market drivers, restraints, and growth of the Global Life Science Analytics market

The ongoing Covid-19 pandemic overburdened the existing healthcare systems and revealed the potential of advanced technologies in supporting the digitalization of healthcare. The Covid-19 pandemic directly impacted the demand for analytical solutions and the market for life science analytics witnessed a significant surge in adoption rates. Analytical solutions were being widely implemented in the management of vaccines, medical supplies, medicines, and other essential resources.

For instance, Moderna entered a partnership with IBM to efficiently manage their vaccination program using advanced analytics and hybrid computing. Moreover, the increasing prevalence of non-communicable diseases, coupled with the growing global geriatric population and growing demand for enhanced patient care experience, is anticipated to contribute to the growing demand for analytical solutions over the forthcoming years. Life science organizations and other healthcare industry players are using analytical solutions in advanced revenue cycle management and population health management programs.

Analytical solutions are being adopted to cater to the rising demand for personalized medication using different human genome combinations using datasets generated through eHealth, mHealth, and electronic health records (EHR). The use of analytical solutions is focused on improving the patient care experience. Furthermore, market players are devising strategies to integrate artificial intelligence-based algorithms into data analytics to efficiently mine data from health datasets, which would aid organizations in customizing different treatment approaches.

Moreover, market players are devising their mergers & acquisitions, product development, and partnership strategies to expand their business footprint and product portfolios. For instance, in April 2020, Accenture signed a definitive agreement to acquire AppsPro, an Oracle Cloud implementation service provider based in Saudi Arabia. Accenture through this acquisition would strengthen its presence and expand its capabilities across the Middle East markets.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

mHealth Market - The global mHealth market size was valued at USD 56.8 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.8% from 2023 to 2030.

eHealth Market - The global eHealth market size was valued at USD 204.32 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 17.4% from 2022 to 2030.

Life Science Analytics Market Segmentation

Grand View Research, has segmented the global life science analytics market on the basis of component, type, application, delivery, end-user, and region:

Life Science Analytics Component Outlook (Revenue, USD Million, 2014 - 2030)

• Software
• Services

Life Science Analytics Type Outlook (Revenue, USD Million, 2014 - 2030)

• Reporting
• Descriptive
• Predictive
• Prescriptive

Life Science Analytics Application Outlook (Revenue, USD Million, 2014 - 2030)

• Research and Development
• Sales and Marketing Support
• Regulatory Compliance
• Supply Chain Analytics
• Pharmacovigilance

Life Science Analytics Delivery Outlook (Revenue, USD Million, 2014 - 2030)

• On-demand
• On-premises

Life Science Analytics End-user Outlook (Revenue, USD Million, 2014 - 2030)

• Medical Device
• Pharmaceutical
• Biotechnology
• Others

Life Science Analytics Regional Outlook (Revenue, USD Million, 2014 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Market Share Insights

May 2021: Wipro and TranscellOncologies partnered to transform vaccine safety assessment using Transcell’s advanced stem cell technology and Wipro Holmes augmented intelligence platform.

March 2021: Cleveland Clinic entered a 10-year partnership contract with IBM to introduce the Discovery Accelerator initiative to focus on discoveries in the healthcare and life sciences industries with the support of artificial intelligence, big data analytics, quantum computing, and cloud computing.

Key Companies profiled:

Some prominent players in the global life science analytics market include:

• Oracle
• IQVIA
• SAS Institute Inc.
• Cognizant
• IBM
• Accenture
• Take Solutions Limited
• Wipro Limited

Order a free sample PDF of the Life Science Analytics Market Intelligence Study, published by Grand View Research.

Procedure Trays Market Segmentation and Growth Prospects Mapping, 2030

Procedure Trays Industry Overview

The global procedure trays market size was valued at USD 15.99 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.3% from 2022 to 2030. The growing number of surgeries globally is a key factor expected to drive the growth of the market for procedure trays during the forecast period. The advent of minimally invasive and non-invasive procedures has increased the number of surgeries performed each year. This is also expected to fuel the product demand in near future.

Patients choose non-invasive or minimally invasive operations to avoid the risk of infections associated with invasive surgeries. Non-invasive operations necessitate shorter hospital stays, saving both time and money. An increase in the frequency of road accidents, an aging population, and increased healthcare spending in emerging economies are expected to increase the number of procedures performed during the projection period. Global healthcare spending is expected to exceed USD 25.00 trillion by 2040, according to the U.S. Census Bureau. Moreover, according to the WHO, the global population aged 60 and up will double by 2050 and reach 2.1 billion.

Gather more insights about the market drivers, restraints, and growth of the Global Procedure Trays market

All the tools and devices needed to perform a specific surgical or diagnostic operation are included in custom procedure kits. Although these kits are not utilized in every medical operation, they are recommended when treating cardiovascular, ophthalmology, and orthopedic ailments and disorders, as well as wound care and dental procedures. Physicians and healthcare practitioners can utilize custom procedure trays to pick clean surgical instruments and tools for single use. The pre-configured and pre-packaged trays and kits minimize the requirement for a massive inventory of individual components. Hence, pre-packaged bespoke procedural solutions help increase the quality of services as they streamline inventory management.

The COVID-19 pandemic positively impacted the procedure trays market due to the increased need for procedure trays to treat the coronavirus-affected population. A continuing shortage of procedure trays, such as testing kits and crucial diagnosis procedure trays has resulted from supply chain disruption. The acute shortfall is caused by a decline in Chinese shipments. The shortage of vital procedure trays is caused by a drop in shipments owing to closed manufacturers and ports.

The increasing number of surgeries and the geriatric population are the factors that drive the market growth in the U.S. According to Regenexx, in the U.S., more than 7 million orthopedic surgeries were performed in 2021. According to the National Center for Health Statistics, more than 40 million surgeries are performed each year, and that number is expected to grow exponentially. In addition, according to the American Psychological Association in 2021, the geriatric population in the country is currently at 46 million and is supposed to double itself by 2060, which is supposed to increase surgeries coupled with advancements in technology and drive the market growth.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Ophthalmic Handheld Surgical Instruments Market - The global ophthalmic handheld surgical instruments market size was valued at USD 2.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.8% from 2022 to 2030.

Angiography Devices Market - The global angiography devices market size was valued at USD 9.8 billion in 2018 and is projected to expand at a CAGR of 6.54% over the forecast period.

Procedure Trays Market Segmentation

Grand View Research has segmented the global procedure trays market based on the product, packaging, end user, and region:

Procedure Trays Product Outlook (Revenue, USD Million, 2017 - 2030)

• Operating Room
• Angiography
• Ophthalmic
• Others

Procedure Trays Packaging Outlook (Revenue USD Million; 2017 – 2030)

• Box
• Mold
• Wrap

Procedure Trays End-user Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals
• Clinics & Other Facilities

Procedure Trays Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle-East and Africa (MEA)

Market Share Insights:

December 2021: American Contract Systems (ACS), a Minnesota-based provider of sterilizing and kitting services for the Custom Procedure Tray (CPT) solution, was acquired by Owens & Minor, Inc. This acquisition will increase their capacity to surpass and meet their customers' collective needs for surgical procedure trays, a market that is predicted to grow rapidly in the near future.

Key Companies profiled

Some prominent players in the global procedure trays market include:

• Owens & Minor, Inc.
• Cardinal Health
• 3M Healthcare
• Teleflex Incorporated
• B. Braun Melsungen AG
• BD
• Merit Medical Systems

Order a free sample PDF of the Procedure Trays Market Intelligence Study, published by Grand View Research.

Legal Marijuana Market Key Companies are Aurora Cannabis and Canopy Growth Corporation

Legal Marijuana Industry Overview

The global legal marijuana market size was valued at USD 16.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 25.4% from 2023 to 2030. The growing demand for legal marijuana has been a primary factor in the growth of the market. Recently, a large number of countries have legalized the use of medical marijuana for treating various ailments. A number of studies carried out show that medical marijuana and its derivatives can be used to treat symptoms of various diseases, for e.g., it has been successfully used to treat patients with chronic pain, chemotherapy-induced nausea, Parkinson’s, Alzheimer’s, and other neurological diseases. The FDA and other such associations have now started accepting the marijuana derivatives for the prescription of diseases in which it has proven to be useful. This is another factor for the quick turnaround of its legal status in a lot of countries. North America (the U.S. and Canada) has gone a step further and has sanctioned the use of recreational marijuana as well and more than two-thirds of the U.S. states have legalized marijuana.

The pandemic severely affected the logistics network for cannabis and its derivatives and due to the ongoing restrictions, the government authorized dispensaries are also facing shortages owing to disruption in the supply chain network. Import and export of nearly all commodities essential or not have been affected as well. However, with the governments endorsing legalization, the demand has risen and is likely to be high in the next few years. Patients are opting for marijuana derivatives instead of the prescription medicines previously being used.

Gather more insights about the market drivers, restraints, and growth of the Global Legal Marijuana market

With the government policies changing, the demand for medical marijuana is also rising. A lot of countries that have legalized the use of medical marijuana are also paving way for its cultivation to cut on the imports and gain revenue in the form of taxes. This, in turn, has generated jobs in the industry and a lot more companies are dabbling in this territory. Several startups in the U.S. and Europe are now focusing on alternate uses of cannabis, other than recreational and medicinal. With so much happening in and around the cannabis industries, the countries are paving way for more liberal policies regarding its cultivation and usage in the medical field as well as industrial use.

The U.S. is seeing a growing number of cultivators for cannabis, including marijuana since this rakes in more revenues for the government and also cuts down on the cost of import. It has a myriad of applications from medical to industrial and since its legalization, the rise in its sale has been exponential and this has generated new opportunities to increase revenues. With the FDA-level authorizations underway, the market for legal marijuana is only going to expand. A large number of clinical trials will support the prowess of marijuana derivatives for it to be legally prescribed for indications.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Cannabis Cultivation Market - The global cannabis cultivation market size was valued at USD 392.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 21.3% from 2023 to 2030.

Medical Marijuana Market - The global medical marijuana market size was valued at USD 13.8 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 21.80% from 2023 to 2030.

Legal Marijuana Market Segmentation

Grand View Research has segmented the global legal marijuana market based on product type, application, and region:

Legal Marijuana Product Type Outlook (Revenue, USD Million, 2016 - 2030)

• Flower
• Oil and Tinctures

Legal Marijuana Application Outlook (Revenue, USD Million, 2016 - 2030)

• Medical
• Adult Use

Legal Marijuana Regional Outlook (Revenue, USD Million, 2016 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Africa

Key Companies profiled:

Some of the prominent players operating in the global Legal Marijuana market are:

• Aurora Cannabis
• Canopy Growth Corporation
• Maricann Group, Inc.
• Aphria, Inc.
• Tilray
• The Cronos Group
• ABcann Medicinals, Inc.
• Lexaria Corp.
• Organigram Holding, Inc.
• GW Pharmaceuticals
• United Cannabis Corporation
• Tikun Olam, Ltd.

Order a free sample PDF of the Legal Marijuana Market Intelligence Study, published by Grand View Research.

Anastomosis Devices Market Top Players are MAQUET Holding B.V. and Co. KG. and Vitalitec International Inc.

Anastomosis Devices Industry Overview

The global anastomosis devices market size was valued at USD 3.58 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030. Rising surgical procedures along with the growing prevalence of cardiovascular and gastrointestinal diseases are the key trends escalating market growth. The surgical practice has been considerably impacted by the outbreak of COVID-19. The pandemic has created challenges for general surgery practice. It has had ramifications for ways of working, open vs minimally invasive, surgical techniques, patient and staff safety, theatre workflow, training, and education. All specialisms have had to triage the importance of their regular surgical procedures and think about non-surgical management options where possible. Many elective or semi-elective procedures including gastrointestinal malignancies have been suspended. However, the market will witness the demand after the commencement of these surgeries at full force.

Moreover, the demand for improved patient outcomes will drive the uptake of novel innovations in anastomosis devices and contributes to market growth. For instance, in December 2020, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic introduced EEA Circular Stapler with Tri-Staple Technology. This is the first 3-row Circular Stapler with wide-ranging height staples is indicated for use in colorectal procedures.

Gather more insights about the market drivers, restraints, and growth of the Global Anastomosis Devices market

The introduction of technologically-advanced products and favorable reimbursement scenarios in cardiac procedures, which comprises Coronary Bypass Graft Surgery (CABG), open-heart valve replacement, and angioplasty in developed countries are boosting the growth of the market for anastomosis devices. For instance, Medicare Part B covers coronary artery bypass graft surgery, coronary angioplasty, valve repair & replacement, and other comprehensive Cardiac Rehabilitation (CR) programs.

The outbreak of COVID-19 impacted elective procedures. Restrictions of COVID-19 resulted in postponements to the number of procedures performed. Presently most countries have elevated restrictions on elective procedures. Consequently, there would be lucrative demand for anastomosis devices as these procedures start with full force. Besides, demand for healthier patient outcomes will drive the introduction of advanced technologies in anastomosis devices and promotes market growth. For instance, in October 2020, GI Windows Corp. raised $16.4 million in a Series A-1 funding that involved investment from Johnson & Johnson Innovation and others. The funds are allotted to improve the development and clinical trials of the firm’s anastomosis technology.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Cardiovascular Anastomosis Devices Market - The global cardiovascular anastomosis devices market size was valued at USD 1.10 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2022 to 2030.

General Surgery Devices Market - The global general surgery devices market size was valued at USD 14.75 billion in 2021 and is expected to grow at a CAGR of 8.29% from 2022 to 2030.

Anastomosis Devices Market Segmentation

Grand View Research has segmented the global anastomosis devices market based on product type, application, end-user, and region:

Anastomosis Devices Product Type Outlook (Revenue, USD Million, 2017 - 2030)

• Disposable
• Reusable

Anastomosis Devices Application Outlook (Revenue, USD Million, 2017 - 2030)

• Cardiovascular Surgery
• Gastrointestinal Surgery
• Others

Anastomosis Devices End-user Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals
• Ambulatory Care Center & Clinics

Anastomosis Devices Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Market Share Insights

March 2021: Vascular Graft Solutions Ltd. received a receipt of marketing authorization from the FDA for the VIOLA. This is a new device for clampless proximal anastomosis in CABG. 

Key Companies profiled:

Some of the prominent players operating in the global anastomosis devices market are:

• Medtronic
• LivaNova PLC
• MAQUET Holding B.V. & Co. KG.
• Dextera Surgical Inc.
• Vitalitec Internaional Inc.
• Synovis Micro Companies Alliance, Inc.
• Ethicon US, LLC
• Peters Surgical

Order a free sample PDF of the Anastomosis Devices Market Intelligence Study, published by Grand View Research.

Neglected Tropical Diseases Diagnosis Market Social Landscape and Consumer Behavior Analysis by 2030

Neglected Tropical Diseases Diagnosis Industry Overview

The global neglected tropical diseases (NTD) diagnosis market size was valued at USD 6.09 billion in 2021 and is expected to expand at a CAGR of 4.4% during the forecast period. Growing awareness of NTDs and an increasing number of initiatives undertaken by the government are anticipated to fuel the market growth. For instance, the inclusion of NTDs in the Sustainable Development Goals (SDG), a United Nations Development Program, as a global target is anticipated to fuel market growth. Furthermore, various initiatives being undertaken by WHO, such as road map 2030 for the elimination of NTDs, are expected to drive market growth during the forecast period.

In the wake of the COVID-19 pandemic, the neglected tropical disease (NTD) diagnosis witnessed a significant decline. WHO launched the Global Program to Eliminate Lymphatic Filariasis (GPELF) in 2000, which aims to stop the spread of the infection and relieve the pain of those who have already been afflicted. However, according to the pulse survey conducted by WHO, as of early 2021, the neglected tropical disease program has faced disruptions in 44% of countries. Moreover, the high risk of transmission of SARS-CoV-2 infection has affected the public health approaches for NTDs. In countries with low health budgets, funds being shifted to tackle other diseases, and a shortage of funding from international partners and the foreign government has significantly impacted the growth of the market.

Gather more insights about the market drivers, restraints, and growth of the Global Neglected Tropical Diseases Diagnosis market

The NTD program has expanded its support to 31 countries in Asia, Latin America, and Africa. Besides, it has provided more than 2.6 billion treatments and leveraged more than USD 22.3 billion in donated medicines. Government organizations such as CDC and WHO collaborate with counties to improve existing public health services for NTDs. Moreover, in January 2021, the WHO introduced its roadmap for NTDs for the period 2021 to 2030. It is aimed to increase the prevention and control of neglected tropical diseases worldwide. Such initiatives undertaken by the government bodies are anticipated to drive the market growth during the forecast period.

Globally, several organizations initiated multiple programs, which contribute to rising in the awareness of NTDs, including the Global NTD Program by the Centers for Disease Control and Prevention, Global NTD Programs by the World Health Organization, NTD Program by the United States Agency for International Development, the United States Global Health Initiative. The primary focus of all these programs is on controlling or eliminating NTDs. Similarly, the London Declaration was initiated to sustain, expand, and extend different programs to support & control guinea worm disease, leprosy, lymphatic filariasis, sleeping sickness, trachoma, schistosomiasis, and Chagas disease by 2020.

The increasing burden of NTDs is considered to be a major factor fueling the growth of the overall market during the forecast period. According to WHO estimates, more than 1.7 billion individuals, about one-fifth of the world’s population, mostly in lower-income and developing countries-required interventions for at least one NTD every year. Around 40% of the African region was affected by NTDs. These diseases are more prevalent among the poor population living in tropical environments and difficult-to-access areas. Countries such as Brazil, Yemen, India, Bangladesh, China, and some countries in Central & East Africa contribute the majority of NTD cases globally.

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

Rapid Tests Market - The global rapid tests market size was valued at USD 1.29 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030.

Saliva Collection and Diagnostics Market - The global saliva collection and diagnostics market size was valued at USD 804.7 million in 2021 and is projected to witness a compound annual growth rate (CAGR) of 8.4% from 2022 to 2030.

Neglected Tropical Disease Diagnosis Market Segmentation

Grand View Research has segmented the neglected tropical disease diagnosis market based on disease, diagnostic method, service type, end-use, and region:

Disease Outlook (Revenue, USD Million, 2014 - 2025)

• Dengue
• Chikungunya
• Rabies
• Leprosy
• Buruli Ulcer
• Yaws
• Lymphatic Filariasis
• Taeniasis/Cysticercosis
• Foodborne Trematodiases
• Echinococcosis
• Chagas Disease (American Trypanosomiasis)
• Dracunculiasis
• African Trypanosomiasis
• Soil-transmitted Helminth Infections
• Onchocerciasis
• Schistosomiasis
• Scabies and Other Ectoparasites
• Snakebite Envenoming
• Leishmaniasis

Diagnosis Diagnostic Method Outlook (Revenue, USD Million, 2014 - 2025)

• Conventional Method
• Molecular/Modern Method

Service Type Outlook (Revenue, USD Million, 2014 - 2025)

• Centralized Service
• POC Service

End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Clinical Labs
• Hospitals /Clinics
• Home Healthcare

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Market Share Insights

March 2021: EUROIMMUN launched the EUROPatternTM Microscope Live (EPML) compact immunofluorescence microscope used to detect antibodies in the sample and enhance the quality of indirect immunofluorescence testing.

Key Companies profiled:

Some of the key players in the global neglected tropical disease diagnosis market include:

• F. Hoffmann-La Roche Ltd
• Abbott
• Thermo Fisher Scientific Inc.
• ZeptoMetrix
• InBios International, Inc.
• Genome Diagnostics Pvt. Ltd.
• Omega Diagnostics Group PLC
• Coris BioConcept
• DiaSys Diagnostic Systems GmbH
• Oscar Medicare Pvt Ltd.

Order a free sample PDF of the Neglected Tropical Disease Diagnosis Market Intelligence Study, published by Grand View Research.

U.S. Sexual Wellness Market is expanding at a CAGR of 7.67% by 2030

U.S. Sexual Wellness Industry Overview

The U.S. sexual wellness market size was valued at USD 10.3 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.67% from 2022 to 2030. The market is anticipated to exhibit lucrative growth in the coming years due to the rising prevalence of Sexually Transmitted Diseases (STDs) and HIV infection. Increasing government initiatives and NGOs participating in promoting the use of contraceptives is expected to boost the market growth. The increasing childbearing population of women in the U.S. and ease of online shopping and e-commerce are expected to further facilitate the sales of sexual wellness products. The NYC Health Department recommended masturbation as the safest form of sexual activity to minimize contact with others and reduce the spread of COVID-19.

Since the pandemic has reduced the stigma around masturbation, an increasing number of customers in the country are opting for various sex toys to improve their sexual experience. The stigma attached to sexual activities & experimenting is reducing due to liberalization and growing acceptance of homosexuality. Sex-positive movements have helped clear the stereotypes related to gender, age, and social construct of people. The banks and investors who were reluctant to fund ventures in sexual wellness products are now investing in this space. 

Gather more insights about the market drivers, restraints, and growth of the U.S. Sexual Wellness market

In recent times, the stereotypical perception has witnessed some change and angel investors are also increasingly investing with manufacturers. For instance, in March 2021, PLBY Group, Inc. spent USD 25 million to buy a TLA acquisition firm that sold sex toys through a subsidiary. Major brands in the U.S. market for sexual wellness are expected to witness lucrative demand due to the growing use of sex toys among both men and women.

U.S. government is also taking initiatives towards sexual wellness by promoting safe sex, further propelling the growth of the market. For instance, in June 2020, the New York health department started a home delivery service called “Door 2 Door” to promote the practice of safe sex. The service provides the delivery of condoms, lubricants, and HIV tests via an online platform.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Sex Toys Market - The global sex toys market size was valued at USD 32.7 billion in 2022. It is expected to expand at a compound annual growth rate (CAGR) of 8.50% from 2023 to 2030.

Condom Market - The global condom market size was valued at USD 10.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.57% from 2023 to 2030.

U.S. Sexual Wellness Market Segmentation

Grand View Research has segmented the U.S. sexual wellness market based on product, distribution channel and region:

U.S. Sexual Wellness Product Outlook (Revenue, USD Million, 2017 - 2030)

• Sex Toys
• Condoms
• Personal Lubricants

U.S. Sexual Wellness Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• E-commerce
• Retailers
• Mass Merchandizers

Market Share Insights

August 2021: Wow Tech and Lovehoney announced a merger and the combined group will be led by Wow Tech with an aim of achieving new heights in sexual wellness.

Key Companies profiled:

Some of the prominent players in the U.S. sexual wellness market include:

• Church & Dwight Co., Inc.
• Reckitt Benckiser Group plc
• Veru Inc.
• Doc Johnson Enterprises
• Mayer Laboratories, Inc.
• LifeStyles Healthcare Pte Ltd
• BioFilm, Inc.
• LELO
• Trigg Laboratories Inc.
• Innovus Pharmaceuticals, Inc.
• Unbound
• CC Wellness

Order a free sample PDF of the U.S. Sexual Wellness Market Intelligence Study, published by Grand View Research.

Who are the Key Players in the Medical Tapes and Bandages Market?

Medical Tapes and Bandages Industry Overview

The global medical tapes and bandages market size was valued at USD 9.05 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.41% from 2022 to 2030. The growth of the market is attributed to the increasing prevalence of chronic diseases such as diabetes, cancer, and other autoimmune diseases, the increasing number of road accidents, and technological advancements, coupled with the increasing adoption of medical tapes and bandages in various healthcare settings such as hospital, clinics, and others.

For instance, according to the 3M company in 2019, 69% of clinicians use medical tape multiple times per day which is expected to boost the market growth. During the outbreak of COVID-19 disease, face masks that are recommended to be used to prevent transmission of the infection can cause serious skin injuries, which may require several wound care products such as medical tapes, bandages, and others for treatment. Thus, the COVID-19 pandemic has shown a positive impact on the market growth owing to its increased demand for critical care capacity and to support hospitals in the fight against COVID-19.

Gather more insights about the market drivers, restraints, and growth of the Global Medical Tapes And Bandages market

The global increase in the incidence of chronic diseases such as cancer, diabetes, and other autoimmune diseases is expected to drive market growth. Moreover, factors such as the adoption of unhealthy & sedentary lifestyles, antimicrobial resistance, smoking, and alcohol consumption are some of the other major factors contributing to the rise in the prevalence of non-communicable diseases. Furthermore, according to the WHO in April 2021, Non-communicable diseases (NCDs) claim the lives of 41 million people each year, accounting for 71% of all deaths worldwide.

The market is predicted to grow during the forecast period due to an increase in the number of surgeries and trauma cases around the world. Trauma is a major cause of death worldwide, with around 5 million people dying every year as a result of traumatic injury. According to the Association for Safe International Road Travel (ASIRT) 2018, every year, between 20 million to 50 million individuals are injured or disabled in traffic accidents, with 1.35 million related deaths. According to the WHO, road traffic injuries are estimated to be the ninth leading cause of mortality globally.

Technological advancements, coupled with product launches, to streamline the procedures and make them safer & more cost-effective, are among the key factors contributing to market growth. For instance, in May 2019, 3M entered into a definitive agreement to acquire the advanced wound care and specialty surgical solutions segments of Acelity and its KCI Subsidiaries, with an aim to expand the company’s product portfolio which is expected to boost the market growth in the near future.

Browse through Grand View Research's Medical Devices Industry Research Reports.

Medical Adhesive Tapes Market - The global medical adhesive tapes market size was valued at USD 750.9 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030.

Traditional Wound Management Market - The global traditional wound management market size was valued at USD 6.2 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 3.7% from 2023 to 2030.

Medical Tapes and Bandages Market Segmentation

Grand View Research has segmented the global medical tapes and bandages market based on product, application, end-use, and regions:

Medical Tapes and Bandages, Product Outlook (Revenue USD Million, 2018 - 2030)

• Medical Tapes
• Medical Bandages

Medical Tapes and Bandages, Application Outlook (Revenue USD Million, 2018 - 2030)

• Surgical Wound
• Traumatic Wound
• Ulcer
• Sports Injury
• Burn Injury
• Other Injuries

Medical Tapes and Bandages, End-Use Outlook (Revenue USD Million, 2018 - 2030)

• Hospitals
• Ambulatory Surgery Centers
• Clinics
• Retail
• Others

Medical Tapes and Bandages, Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Market Share Insights

September 2021: Lohmann and Soest Medical Group (SMG) agreed that SMG will take over Lohmann's reusable drape tape business. This acquisition includes drape tapes such as DuploMED 2806 and DuploMED VP6141 which are aimed at the reusable surgical drape market, as well as Lohmann's global client base for these tapes.

April 2019: Smith & Nephew PLC purchased Osiris Therapeutics, Inc. with the goal of speeding up the development of its medical bandages and tapes product line, thus boosting its client base and market reach. 

Key Companies profiled:

Some prominent players in the global medical tapes and bandages market include:

• Smith & Nephew PLC
• Mölnlycke Health Care AB
• Ethicon Inc. (JOHNSON & JOHNSON)
• Medtronic
• 3M
• Beiersdorf AG
• Urgo Medical
• Dynarex Corporation
• Winner Medical Group, Inc.
• McKesson Corporation
• Cardinal Health
• 3L Medicinal Products Group
• Braun Melsungen AG
• Paul Hartmann AG

Order a free sample PDF of the Medical Tapes and Bandages Market Intelligence Study, published by Grand View Research.

Increasing Incidence of Eye Disorders accelerates Ocular Implants Market Growth by 2030

Ocular Implants Industry Overview

The global ocular implants market size was valued at USD 13.30 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030. Increasing incidence of eye disorders such as age-related macular degeneration, cataract, glaucoma, and scleritis is the major factor anticipated to drive the market. The increase in the incidence rate is leading to a rise in demand for surgical procedures that require ocular implants. For instance, according to a research article published by the U.S. National Library of Medicine, based on the earlier trends in cataract surgeries, it is anticipated that 3.7 million cataract surgeries must have been performed among the Medicare beneficiaries in 2020 in the U.S. 

The novel COVID-19 disease has disrupted the overall flow and working of some of the major economies across the globe while having an equal impact on the emerging and smaller economies as well. The outbreak led to major loss of life and created a sense of panic among the population, globally. Therefore, in order to control the spread of the virus and reduce the mortality rate due to the infection of the virus, various restrictions and guidelines were imposed by different countries. Many countries observed a strict lockdown, which led to a postponement of elective surgeries, resulting in the reduction of demand for ocular implants. This implies that the pandemic had a negative impact on the market.

Gather more insights about the market drivers, restraints, and growth of the Global Ocular Implants market

However, in the long run, the pandemic is expected to have a slightly positive impact on the sales of ocular implants. One major factor that indicates this is the major shift towards online education programs and work from home model. This is leading to a higher percentage of the population being exposed to a relatively high amount of screen time, which can lead to the risk of developing eye disorders. The pandemic resulted in major disruptions of the supply chain initially due to the lack of planning.

As a result, major losses were incurred, which compelled the manufacturers to create strategic plans that can help to avoid any similar situation in the future. Moreover, with the opening of the economies, the demand for these procedures has elevated to a great extent due to the earlier backlog surgeries and increasing focus on multiple awareness programs. Thus, although the COVID-19 pandemic did have a negative impact on the market initially, the market is expected to regain its growth and grow at an exponential rate over the forecast period.

Eye diseases such as cataracts and age-related macular degeneration are age-related diseases. An increase in the geriatric population is another factor contributing to the growth of the market. Additionally, increasing adoption of a sedentary lifestyle and the rising prevalence of diabetes may lead to diabetic retinopathy, which is anticipated to boost the sales of ocular implants. For instance, according to the International Diabetes Federation, in 2021, approximately 537 million individuals were living with diabetes and it is anticipated to rise to 643 million by 2030. 

Technological advancement is yet another factor playing an important role in propelling market growth. The introduction of micro-invasive glaucoma devices for patients suffering from glaucoma is a classic example of the technology that has evolved over the last few years. For instance, Glaukos Corporation received FDA approval for its second-generation trabecular meshwork bypass stent, iStent Inject in June 2018. The device is indicated for the treatment of mild to moderate glaucoma and is approved for implantation at the time of phacoemulsification. 

Browse through Grand View Research's Medical Devices Industry Research Reports.

Ocular Trauma Devices Market - The global ocular trauma devices market size was valued at USD 3.52 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.2% over the forecast period from 2022 to 2030.

Ocular Adhesives and Sealants Market - The global ocular adhesives and sealants market size was valued at USD 136.7 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.28% from 2022 to 2030.

Ocular Implants Market Segmentation

Grand View Research has segmented the global ocular implants market based on product, application, end use, and region:

Ocular Implants Product Outlook (Revenue, USD Million, 2017 - 2030)

• Intraocular Lens
• Corneal Implants
• Orbital Implants
• Glaucoma Implants
• Ocular Prosthesis
• Others

Ocular Implants Application Outlook (Revenue, USD Million, 2017 - 2030)

• Glaucoma Surgery
• Oculoplasty
• Drug Delivery
• Age-related Macular Degeneration
• Aesthetic Purpose

Ocular Implants End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals
• Specialty Eye institutes
• Clinics

Ocular Implants Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Market Share Insights

August 2021: Alcon, Inc., a subsidiary of Novartis, acquired Ivantis, Inc. and its HydrusMicrostent for surgical glaucoma. The intended acquisition supports Alcon’s commitment to further strengthen its industry-leading portfolio across refractive, retina, cataract, and glaucoma.

Key Companies profiled:

Some prominent players in the global ocular implants market include:

• Alcon, Inc.,
• Bausch & Lomb, Inc.
• Carl Zeiss AG
• Johnson & Johnson
• STAAR Surgical Company
• Morcher GmbH
• Hoya Corporation
• Glaukos Corporation

Order a free sample PDF of the Ocular Implants Market Intelligence Study, published by Grand View Research.

Veterinary Software Market is driven by Increase in Number of Zoonotic and Chronic Diseases

Veterinary Software Industry Overview

The global veterinary software market size was valued at USD 494.0 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.0% from 2022 to 2030. Increasing demand for Practice Management Systems (PMS) from veterinary practitioners is a key contributor to the market growth. In addition, growing awareness regarding the benefits of the use of software solutions and an increasing number of clinical visits by pet owners are expected to boost the adoption of software solutions in veterinary practices in the coming years. The animal health industry is impacted by an increase in companion pet ownership and concerns over pet health. A growing focus on the efficiency and safety of livestock production is also another growth propeller.

Developers of PMS systems offer complete solutions for the management of a veterinarian’s office including maintaining schedules and records. As per the data published by the American Veterinary Medical Association, approximately 68,000 veterinarians in North America and around 22,000 in the United Kingdom are practicing privately. This number is further expected to increase over the forecast period. This increase in the number is anticipated to propel the demand for these solutions for managing operations in clinics and reference laboratories.

Gather more insights about the market drivers, restraints, and growth of the Global Veterinary Software market

The outbreak of COVID-19 is estimated to have a considerable impact on the growth of the market. In most regions, veterinary services are considered essential services and remained functional even during the lockdown. This has contributed notably to the continuation of revenue generation across veterinary practices, in turn, leading to the growth of this market. The COVID-19 pandemic brought drastic changes to patients’ normal routine with lockdown and social distancing measures across the world. Understandably due to loneliness and disturbed mental health experienced by most of the population during the pandemic, the adoption of companion animals witnessed an upsurge.

Citing an example, according to the Japan Pet Food Association survey, there has been a 15% increase in dog and cat ownership in 2020, as compared to the previous year. There were an estimated 8.49 million dogs and 9.64 million cats being kept as pets in Japan as of October 2020. This thereby resulted in an increase in the demand for virtual pet care visits during the pandemic and thus high adoption of veterinary software solutions. Over the years, the number of pet owners has increased significantly, and this trend is expected to continue in the coming years. According to the American Pet Products Association, approximately 33% of the owners owned a dog and 27% of the pet owners owned cats. Overall, it was estimated around 59% in 2021. Hence, the increasing adoption of pets further accelerates market growth. 

Browse through Grand View Research's Animal Health Industry Research Reports.

Veterinary MRI Market - The global veterinary MRI market size was valued at USD 205.93 million in 2022 and is expected to expand at a lucrative compound annual growth rate (CAGR) of 7.38% from 2023 to 2030.

Livestock Monitoring Market - The global livestock monitoring market size was valued at USD 4.62 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 17.63% from 2022 to 2030.

Veterinary Software Market Segmentation

Grand View Research has segmented the global veterinary software market on the basis of product, delivery mode, practice type, end use, and region:

Veterinary Software Product Outlook (Revenue, USD Million, 2017 - 2030)

• Practice Management Software
• Imaging Software

Veterinary Software Delivery Mode Outlook (Revenue, USD Million, 2017- 2030)

• On-premise
• Cloud/Web-based

Veterinary Software Practice Type Outlook (Revenue, USD Million, 2017 - 2030)

• Small Animals
• Mixed Animals
• Equine
• Food-producing Animals
• Others

Veterinary Software End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals/Clinics
• Reference Laboratories

Veterinary Software Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Market Share Insights

August 2021: Petabyte Technology proclaimed a partnership to advance the lives of veterinarians, their teams, and pet parents through innovative software. Together, the two corporations proposed to advance the next development of Petabyte's software to revolutionize animal hospital operations and transform the pet parent experience.

June 2021: The Veterinary Hospitals Association has entered a partnership contract with PetDesk. This agreement is to offer all Veterinary Hospitals Association members special access to enhanced, simplified client communication solutions.

Key Companies profiled:

Some prominent players in the global veterinary software market include:

• IDEXX Laboratories, Inc.
• Hippo Manager Software, Inc.
• VetZ Limited
• Esaote SpA
• Henry Schein, Inc.
• Patterson Companies, Inc.
• ClienTrax
• VIA Information Systems
• Onward Systems, Inc.
• Animal Intelligence Software
• ezyVet
• Provet Cloud
• VitusVet
• DaySmart Software
• NaVetor

Order a free sample PDF of the Veterinary Software Market Intelligence Study, published by Grand View Research.

Protein Purification and Isolation Market Size, Share and Trends Analysis Report by Technology, 2030

Protein Purification and Isolation Industry Overview

The global protein purification and isolation market size was valued at USD 7.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.6% from 2022 to 2030. Growing research in the areas of pharmaceutical and biotechnology for the development of novel drugs drives the demand for protein purification and isolation. Furthermore, rising investments in R&D by pharmaceutical manufacturers are projected to drive the market. The unexpected COVID-19 outbreak prompted the implementation of lockdown rules across the globe, causing delays in protein purification and isolation import and export. The pandemic also lowered the availability of funds from private investors and governments around the world. Purification and isolation of proteins refer to a set of procedures for isolating a specific protein from a complicated combination of cells, organisms, or tissues.

Protein research requires these techniques to separate, concentrate, stabilize, and eliminate contaminants including endotoxins, viruses, and nucleic acid. They involve determining material and maintaining a purification table to track the enzyme's development. They are mostly used to classify a protein's function, structure, and interactions. Affinity chromatography, immunoprecipitation, proteomics, and enzyme assay are some of the regularly utilized methods of protein purification and separation. Over the pandemic, the disruption in the process had a negative impact on the market, but increased government funding for R&D is enabling the market to recover, and the market is expected to grow during the forecast period.

Gather more insights about the market drivers, restraints, and growth of the Global Protein Purification and Isolation market

Governments are increasingly investing in R&D and undertaking initiatives that promote the development and growth of the pharmaceutical and biotechnology markets. They also provided added benefits via tax incentives, grants, and investment-friendly regulations among others. Pharmaceutical is a highly lucrative industry for protein purification and isolation solutions owing to significant investments in the development of biomarker-specific molecules. Precise isolation of proteins with a significant amount of purified substrate is a vital component of the preclinical drug development phase.

Ongoing technological advancements further drive the market for protein purification and isolation solutions. Magnetic and protein beads and ligand tagging systems are increasingly preferred over traditional methods such as agarose beads and other resins. Furthermore, the rising usage of automated analyzers is projected to drive the demand for purification and isolation solutions.

The rising significance of discovering novel ligands, such as protein-based therapeutic compounds, is a major factor fueling the market expansion. Additionally, rising demand for purification kits in rapid screen tests, a shift towards technologically advanced instrumentation for protein purification, growth of the proteomics market, and increasing R&D in pharmaceutical and biotechnological fields are expected to propel the market growth. However, instruments that result in a reduced acceptance rate, the difficulty of maintaining purification kits that fit all proposes, and high tool costs are acting as hurdles to market growth. In addition, the protein purification and isolation industry is benefiting from untapped growth markets and protein therapies.

Browse through Grand View Research's Biotechnology Industry Research Reports.

Protein A Resin Market - The global protein A resin market size was estimated at USD 1.36 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.49% from 2023 to 2030.

Nucleic Acid Isolation and Purification Market - The global nucleic acid isolation and purification market size was valued at USD 4.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2021 to 2028.

Protein Purification and Isolation Market Segmentation

Grand View Research has segmented the global protein purification and isolation market based on product, technology, application, end-use, and region:

Product Outlook (Revenue, USD Million, 2017 - 2030)

• Instruments
• Consumables

Technology Outlook (Revenue, USD Million, 2017 - 2030)

• Ultrafiltration
• Precipitation
• Chromatography
• Electrophoresis
• Western blotting
• Others

Application Outlook (Revenue, USD Million, 2017 - 2030)

• Drug Screening
• Biomarker Discovery
• Protein-protein Interaction Studies
• Diagnostics

End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Academic and Research Institutes
• Hospitals
• Pharmaceutical and Biotechnological Companies
• CROs

Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

Market Share Insights

March 2022: Thermo Fisher Scientific and Symphogen announced that they would continue the collaboration to provide biopharmaceutical research and development laboratories and platform workflows for quality monitoring and simplified characterization of complex therapeutic proteins.

December 2021: GE Healthcare Life Sciences announced that it has completed its acquisition of BK Medical, from Altaris Capital Partners, LLC for an upfront cash payment of USD 1.45 billion in September 2021.

Key Companies profiled:

Some prominent players in the global protein purification and isolation market include:

• Merck KGaA
• Thermo Fischer Scientific, Inc.
• GE Healthcare Life Sciences
• Qiagen N.V.
• Sigma-Aldrich Corporation
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• Promega Corporation
• Abcam
• Norgen Biotek Corporation

Order a free sample PDF of the Protein Purification and Isolation Market Intelligence Study, published by Grand View Research.

mHealth Apps Market Prominent Companies are Johnson & Johnson and AstraZeneca PLC

mHealth Apps Industry Overview

The global mHealth apps market size was valued at USD 43.5 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.6% from 2023 to 2030. Growing adoption of fitness and medical apps to collect and track individuals' health-related data and to improve the overall health of the patients’ using smartphones are the major factors anticipated to drive the market. In addition, increasing internet and smartphone penetration and growing awareness in maintaining physical health and lifestyle improvement are also further increasing the adoption, thereby supporting market growth.

Furthermore, increasing promotion to adopt health applications by the government and private organizations due to the benefits provided by these applications in monitoring and improving health conditions and lifestyle is also expected to accelerate the app adoption over the years. In addition, the growing number of health applications and continuous improvement of the app quality by the developers is also anticipated to boost the growth of the market for mHealth. For instance, according to statistics quoted by IQVIA in an article published by Medical Device Network in 2021, are more than 350,000 digital health applications available on app stores.

Gather more insights about the market drivers, restraints, and growth of the Global mHealth Apps market

The growing interest of the users to use health applications for chronic disease management is expected to increase the adoption of mobile health applications. In addition, increasing recommendations of healthcare professionals to use mobile applications for better patient care is also another factor anticipated to accelerate the mHealth app adoption. For instance, according to the data published in OrthoLive stated that 93% of the healthcare professionals believed that mobile health applications can improve patients' health. This type of perspective of the healthcare professionals towards the mobile health applications is further anticipated to drive the adoption of the mHealth applications over the years.

Furthermore, an increase in the number of mobile subscriptions and growing internet penetration around the globe are further helping to boost the adoption of health applications. For instance, as per the report published in 2020 by Ericsson, the mobile subscription number exceeded six billion and this is also anticipated to increase over the forecast years. Moreover, the growing use of social media and increasing app promotions are also expected to propel the growth of the market for mHealth in the upcoming years. For instance, according to the DataReportal 2021 statistics, there are around 4.55 billion social media users by October 2021, which equates to 57.6% of the total world population.

In addition, there is an increase in the utilization of mHealth applications observed during the COVID-19 pandemic. During the pandemic, the government and non-government organizations promoted the use of mobile health applications for training, self-management of symptoms, information sharing, contact tracing, risk assessment, home monitoring, and decision making to manage the COVID-19 pandemic. For instance, as per the data published in the journal Expert Review of Pharmacoeconomics and Outcomes Research, there is a 65% growth in mobile health application download in 2020.

Moreover, data security and privacy concerns of mobile healthcare applications are the major factors expected to hamper the growth of the market for mHealth. Sensitive information accesses, hacking issues, data breaches, automatic installation of malicious programs are some of the major concerns anticipated to impede the market growth. In addition, lower regulatory approval for mHealth applications is also one of the major factors anticipated to restrain the growth of the market. For instance, as per the medical economics report, only 219 mobile health applications got FDA approval by 2018.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

mHealth Market - The global mHealth market size was valued at USD 56.8 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.8% from 2023 to 2030.

Digital Health Market - The global digital health market size was valued at USD 211.0 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 18.6% from 2023 to 2030.

mHealth Apps Market Segmentation

Grand View Research has segmented the global mHealth apps market based on product type, platform and region:

mHealth Apps Product Type Outlook (Revenue, USD Million, 2016 - 2030)

• Medical Apps
• Fitness Apps

mHealth Apps Platform Outlook (Revenue, USD Million, 2016 - 2030)

• Android
• iOS
• Others

mHealth Apps Regional Outlook (Revenue, USD Million, 2016 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East Africa

Market Share Insights

April 2020: The prime minister of India launched the Arogya Setu app to track the COVID 19 cases across India.

October 2019: Abbott Laboratories announced its partnership with Omada Health for diabetic care management using the mhealth coaching platform.

Key Companies profiled:

Some of the prominent players in the mhealth apps market include:

• Teladoc Health, Inc.
• Abbott Laboratories
• Johnson and Johnson
• AstraZeneca PLC
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc
• Merck and Co., Inc.
• Pfizer, Inc.
• Sanofi

Order a free sample PDF of the mHealth Apps Market Intelligence Study, published by Grand View Research.

Surgical Dressings Market Porter's Five Forces Analysis and Technology Landscape, 2030

Surgical Dressings Industry Overview

The global surgical dressing market size was estimated at USD 3.6 billion in 2021 and is anticipated to grow at a compound annual growth rate (CAGR) of more than 5.56% during the forecast period. The market is majorly driven by the rising number of surgeries across the globe. For instance, as per an article published in NCBI (2020), every year, approximately 310 million major surgeries are performed worldwide; amongst which approximately 40 to 50 million are in the U.S. and 20 million in Europe. Moreover, according to a survey by the National Quality Forum, the number of surgical procedures conducted in the U.S. is increasing every year, and the rate of surgeries performed in ambulatory surgery centers has surged by 300% since the last decade. Furthermore, according to the American Society of Plastic Surgeons, approximately 18 million people in the U.S. underwent minimally invasive cosmetic surgical procedures in 2018.

Similarly, Regenexx estimated that approximately 7 million orthopedic surgeries were performed in the U.S. in 2017, out of which 242,000 adults who were below 65 years of age had a hip or knee implant. Surgeries may lead to surgical site infections if the wound is not cleaned properly. According to Infectious Disease Advisor, 5% of total surgeries performed resulted in surgical site infections. Therefore, with the increase in the number of surgeries performed, the use of surgical wound dressings is anticipated to grow during the forecasted period.

Gather more insights about the market drivers, restraints, and growth of the Global Surgical Dressings market

The COVID-19 pandemic had negatively impacted the market, mainly owing to the cancellation or delay of elective surgical procedures. Moreover, there was a slight impact on the number of patients visit to wound care centers, and outpatient clinics, especially in the U.S. For instance, as per the research survey published by Tissue Analytics, a Net Health company, there was an estimated 40% decline in patient visits to wound care centers during March & April 2020, as compared to 2019.

However, post-pandemic the sector is recovering gradually, as the healthcare providers have shifted to new modes of care for surgical wounds such as virtual consultations and telehealth platforms. Following the latest insights published on MobiHealthNews (HIMSS) in October 2021, the National University of Singapore in collaboration with Singapore General Hospital developed VeCare. It’s a point-of-care wound evaluation platform that comprises a smart bandage with sensors and a smartphone app for remote wound monitoring. The wearable device can detect factors of chronic wounds within 15 minutes. Furthermore, several studies have found that telemedicine options are a cost-effective way to improve wound care outcomes while also increasing patient compliance and satisfaction. The Centers for Medicare and Medicaid Services (CMS) recently updated the list of reimbursable such services. Thus, due to the aforementioned factors, the market is anticipated to gain a significant growth rate in the post-pandemic period. 

Browse through Grand View Research's Medical Devices Industry Research Reports. 

Advanced Wound Dressing Market - The global advanced wound dressing market was valued at USD 7.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 2023 to 2030.

Anti-biofilm Wound Dressing Market - The global anti-biofilm wound dressing market was valued at USD 714.7 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2030.

Surgical Dressing Market Segmentation

Grand View Research has segmented the global surgical dressing market report based on product, application, end-use, and region:

Surgical Dressing Product Outlook (Revenue, USD Million, 2018 - 2030)

• Primary Dressing
• Secondary Dressing
• Others

Surgical Dressing Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diabetes Based Surgeries
• Cardiovascular Diseases
• Ulcers
• Burns
• Transplant Sites
• Others

Surgical Dressing End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital
• Specialty Clinics
• Home Healthcare
• Ambulatory Surgery Centers
• Others

Surgical Dressing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• Europe
• Asia-Pacific
• Latin America
• MEA

Market Share Insights

December 2021: Medline enhanced the healthcare supply chain with an investment of USD 1.5 billion in the Richmond Hill distribution center. Medline opened 5 new distribution centers in 2021, whereas, two more distribution centers are projected for completion in the year 2022.

Key Companies profiled:

Some prominent players in the global surgical dressing market include:

• 3M
• Smith & Nephew
• Mölnlycke Health Care AB
• ConvaTec Group PLC
• Johnson & Johnson
• Baxter International
• Coloplast Corp.
• Medtronic
• Derma Sciences Inc. (Integra LifeSciences)
• Cardinal Health

Order a free sample PDF of the Surgical Dressings Market Intelligence Study, published by Grand View Research.